AXGN AxoGen, Inc.

AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries.

$13.75  +0.13 (0.95%)
As of 10/18/2021 15:59:53 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  41,397,053
Average volume:  129,303
Market cap:   $567,139,626
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    05463X106
ISIN:        US05463X1063
Valuation   (See tab for details)
PE ratio:   -25.57
PB ratio:   4.74
PS ratio:   4.34
Return on equity:   -18.57%
Net income %:   -16.89%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy